Eurofins Bioanalytical Services’ Post

Exciting news in the clinical trial space! 🚀 Labcorp has just launched Global Trial Connect, a suite of digital and data solutions designed to accelerate clinical trials. Key features include: ✅ Site enablement resources ✅ Supply readiness support ✅ Site workflow facilitation ✅ Study management and investigator support This development could significantly impact the speed at which new therapies reach patients. What are your thoughts on how technology is transforming clinical trials? #ClinicalTrials #HealthcareInnovation #Labcorp #MedicalResearch

What? Free training? My motto: Always say yes to free training.

With the increasing complexity of modern clinical trials and growing restraints on internal resources, it can be a challenge to meet today’s study demands. Get the insights you need for success during AAPS PharmSci 360! Hear from LabConnect’s experts at these two sessions: 💡 Overcoming Global Analytical Challenges with Scientific Central Lab Expertise (10/22 at 11am) 💡 Overcoming Challenges: ctDNA Liquid Biopsies in Early Phase Clinical Trials (10/22 at 3:30pm) Need support now? Arrange a dedicated meeting time with our team by emailing ADSTeam@LabConnect.com.  #PharmSci360 #ClinicalResearch #DrugDevelopment  American Association of Pharmaceutical Scientists (AAPS) | @aapscomms Stacy Kirn-Barker John Bauer

EARLY REGISTRATION ends March 1. Rates increase $100 on March 2: ifopa.org/2024_fop_ddf The DDF brings together biotech and pharmaceutical companies, academic researchers and clinician scientists to collaborate and advance FOP research. It's an opportunity to discuss emerging FOP data and highlight gaps in our understanding of FOP disease pathogenesis that could offer new therapeutic options. Due to the nature of the content, the DDF is a meeting designed only for researchers, clinician scientists, pharmaceutical/biotech employees, and employees of regulatory agencies.

Your clinical biomanufacturing program can be derailed if you don't pay attention to tech transfer details. Sponsors and CDMOs are eager to get contracts signed, but often overlook the crucial steps in the tech transfer process that will set the program up for success. On March 5 at 2:00pm ET, Scorpius BioManufacturing, Inc. will host a webinar discussing: 💡 The nuances of tech transfer that matter most 💡 How to prepare for tech transfer before you select a CDMO 💡 Key mistakes to avoid during the tech transfer process Listen in as Kristofer Morton, Brian O'Mara, Rhea Paige Annolino, & Abby Sorensen join Pharmaceutical Technology and BioPharm International for a 30-minute crash course on tech transfer best practices. Register at: https://lnkd.in/dFx_TFBT

LAST CHANCE to register early before rates increase $100 on March 2: ifopa.org/2024_fop_ddf The DDF brings together biotech and pharmaceutical companies, academic researchers and clinician scientists to collaborate and advance FOP research. It's an opportunity to discuss emerging FOP data and highlight gaps in our understanding of FOP disease pathogenesis that could offer new therapeutic options. Due to the nature of the content, the DDF is a meeting designed only for researchers, clinician scientists, pharmaceutical/biotech employees, and employees of regulatory agencies.

It was great meeting bright minds from Biotech/Pharma at #BiotechTuesday event and discussing Drug Development pathway! The insights received from the leaders in the Industry are always impressive! #drugdevelopment #cmc #preformulation #formulation #manufacturing #drugsubstance #drugproduct #research

[Expert interview] 🤝 Meet our technical expert in #preformulation studies, Dr. Sonia Lombardo. Sonia holds a PhD in biopharmacy and pharmaceutical biology and works at SEQENS as a preformulation and solid state engineer since 2022.    We asked her 5 questions : ✔️ What is your background? ✔️ How crucial are pre-formulation studies for drug substance development at early-stage? ✔️ If an API has low bioavailability properties, what are the best strategies to improve it? ✔️ Typically, how long does it take to run preformulation studies for preclinical assays? ✔️ How do you deal with an API exhibiting poor permeability, such as BCS/DCS class III drug?   Discover her answers below and read the full article in our knowledge center ➡️ https://lnkd.in/gNJax6Rk   Within our SeqensUP! offer, our dedicated team offers solutions for solving bioavailability issues of APIs. Contact cro@seqens.com to know more!

The FIP biowaiver monographs contain a comprehensive summary of literature data relevant to the application of biowaivers based on the Biopharmaceutics Classification System (BCS). These monographs are compiled for all drug substances that are included on the WHO Model List of Essential Medicines. A free virtual issue with previously published biowaiver monographs is now available. This includes one of our contributions to the biowaiver monographs series containing the relevant literature data pertaining to the anthelminthic drug levamisole. The issue contains a wealth of data and is especially of interest when you are working on related topics. Find the virtual issue here: https://lnkd.in/ePpmfwAb Find the Levamisole biowaiver monograph here: https://lnkd.in/e7RsKdp8

Excited to kickoff one of the top conference for clinical operations. My main goal: Learn, discuss and share ideas on how Data & AI can transform clinical trial execution to improve patient outcome around the world. #SCOPEsummit #perficient #data #ai